Biliary cystadenoma and cystadenocarcinoma laboratory findings

Biliary cystadenoma and cystadenocarcinoma Microchapters
Home
Patient information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Biliary cystadenoma and cystadenocarcinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Biliary cystadenoma and cystadenocarcinoma laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Biliary cystadenoma and cystadenocarcinoma laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Biliary cystadenoma and cystadenocarcinoma laboratory findings
CDC on Biliary cystadenoma and cystadenocarcinoma laboratory findings
Biliary cystadenoma and cystadenocarcinoma laboratory findings in the news
Blogs on Biliary cystadenoma and cystadenocarcinoma laboratory findings
Directions to Hospitals Treating Biliary cystadenoma and cystadenocarcinoma
Risk calculators and risk factors for Biliary cystadenoma and cystadenocarcinoma laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]

Laboratory Findings

• Laboratory tests may show leukocytosis with a left shift in case of superinfection of the tumor.
• Elevation of alkaline phosphatase and bilirubin may be present.
• CA 19-9 may be elevated in the serum and in the cystic fluid, while CEA and α-fetoprotein levels are usually normal.

Cystic fluid analysis

Cystic fluid analysis during laparoscopy is advocated in the surgical treatment of hepatic cysts. In fact, the presence of elevated intracystic levels of CA 19-9 can support the diagnosis of cystadenoma. Therefore, it was concluded that CA 19-9 levels can differentiate between simple hepatic cyst and cystadenoma, and that cyst fluid analysis should always be performed, allowing to spare those patients with asymptomatic simple cyst from aggressive surgical treatment.